Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Cellular and Infection Microbiology"
DOI: 10.3389/fcimb.2022.980844
Abstract: Mycobacterium tuberculosis remains a leading cause of infectious disease morbidity and mortality for which new drug combination therapies are needed. Mycobacterial bioenergetics has emerged as a promising space for the development of novel therapeutics. Further…
read more here.
Keywords:
mycobacterium tuberculosis;
respiratory complexes;
respiratory;
mycobacterial respiratory ... See more keywords